AI can now detect breast cancer, French startup raises €5M funding to expand in radiology market

With reports suggesting that one in eight women are affected by breast cancer, breast imaging becomes one of the most sought after radiology specialities. However, the diagnosis of this type of cancer is quite challenging as only a meagre 0.5% of mammograms contain the cancerous tissue and 10% of the tests still yield false positives.

Therapixel raises €5M funding

Paris-based medtech startup Therapixel resolves this issue by applying artificial intelligence (AI) to radiology so that radiologists can better diagnose breast cancer. Founded in 2013 by Olivier Clatz and Pierre Fillard, Therapixel has raised €5 million in Series A funding from Omnes and M Capital Partners along with participation from existing investors Région Sud Investissement, IT-Translation and Credit Agricole.

Please keep reading..

As the coronavirus pandemic unfolds in the world, we at Silicon Canals are committed to...Show More

As the coronavirus pandemic unfolds in the world, we at Silicon Canals are committed to creating the biggest possible impact on the technology industry and startup ecosystem by bringing quality journalism to your devices. But today we rely on our readers to support us. We are asking you a big favour to make a contribution and support our editorial team to continue to investigate and write some insightful stories for you during these crisis times. We want to stand by you and do whatever it takes to bring the best news content to you.Our stories are free to read, exclusive, unbiased and always with an edge and with your financial support, we can keep the wheel spinning independently. Our online news platform is run by a small, independent publisher without any form of external capital or grants but still, we plan to stay here for long.We’d like to thank you in advance for your contribution! Each donation, however big or small, means a lot. Support Silicon Canals from as little as €10 – it will only take a minute. Thank you again.Show Less

Read more

The French medtech startup demonstrated its ability to develop the best AI-based algorithms in the world for breast cancer screening. Therapixel won the DREAM Digital Mammography Challenge in 2017, which is the largest AI competition organised ever with over 1,200 participants and $1.2 million prize reward.

“Therapixel is entering a new and exciting phase,” said Pierre Fillard, co-founder and CEO of Therapixel. “With this financing round and the strengthening of our governance, I am confident that we will continue to attract the best talents and maintain our leadership.”

“Therapixel has proven to be a leader in the field of AI applied to one of the key challenges in cancer screening,” added Sacha Loiseau, Chairman of Therapixel. “I am delighted to join the company at this key moment and to work hand in hand with Pierre and his team to bring value to our shareholders.”

Stay tuned to Silicon Canals for more updates in the tech startup world.

Also read,

5 most successful crowdfunding campaigns on the most active funding platform in UK

Working on next big innovation in health & nutrition?

How do we create a world where we can feed a population of 9 billion, and keep all those...Show More

How do we create a world where we can feed a population of 9 billion, and keep all those people healthy? Show Less

Read more